Bandaram Pharma Packtech Quarterly Results for Trading Insights
In Sept 2025, Bandaram Pharma Packtech (BANDARAM) reported revenue ₹14 Cr and net profit ₹0 Cr — revenue +100.0% YoY. For annual financials, live price and key ratios, visit Bandaram Pharma Packtech share price screener.
BANDARAM Quarterly Results — Revenue, Profit & EPS Highlights
Bandaram Pharma Packtech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore BANDARAM stock price history to track price trends across different timeframes.
- Revenue of ₹14 Cr in Sept 2025 (+55.6% vs Mar 2025, +100.0% vs Sept 2024)
- EBITDA of ₹1 Cr in Sept 2025 (+0.0% vs Mar 2025)
- Operating Margin of 3.0% in Sept 2025 (-3.0pp vs Mar 2025)
- Earnings Per Share of ₹0.03 in Sept 2025 (-76.9% vs Mar 2025)
Bandaram Pharma Packtech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
BANDARAM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 14 | 9 | 8 | 15 | 7 | 55.6% | 100.0% |
| Net Profit (₹ Cr) | 0 | 0 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 1 | 1 | 1 | 1 | 1 | - | - |
| EPS (₹) | 0.03 | 0.13 | 0.02 | 0.11 | 0.31 | - | - |
| Operating Margin (%) | 3.0% | 6.0% | 8.0% | 7.0% | 15.0% | - | - |
BANDARAM Share Price Trend — 1-Year Movement Across Quarterly Results
Bandaram Pharma Packtech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with BANDARAM fair value estimate to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
BANDARAM vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Bandaram Pharma Packtech latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹118,945.86 Cr | 8272.5 | 6,660 | 551 | +4.6% | +17.6% | 8.3% | 224.7 |
|
Max Healthcare Inst…
Sept 2025 |
₹96,724.76 Cr | 993.5 | 2,168 | 491 | +10.8% | - | 22.6% | 196.7 |
|
Fortis Healthcare
Mar 2026 |
₹73,257.36 Cr | 960.9 | 2,375 | 271 | -0.3% | +16.9% | 11.4% | 273.0 |
|
Aster DM Healthcare
Mar 2026 |
₹39,252.85 Cr | 741.3 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 272.5 |
|
Narayana Hrudayalaya
Mar 2026 |
₹38,951.17 Cr | 1920.2 | 2,623 | 224 | +57.3% | +74.5% | 8.5% | 174.2 |
All amounts in ₹ Crores